SDP MERS
(Die Seite wurde neu angelegt: „{{nosys}} {{tp|p=32213260|t=2020. Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.|pdf=|usr=015}} {{tp|p=32145185|t=2020. Mid…“) |
|||
Zeile 1: | Zeile 1: | ||
{{nosys}} | {{nosys}} | ||
− | + | ||
− | + | ||
− | + | ||
− | {{tp|p= | + | {{tp|p=24456414|t=2014. Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005.|pdf=|usr=015}} |
− | + | {{tp|p=26256102|t=2017. Dromedary Camels and the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV).|pdf=|usr=015}} | |
− | + | {{tp|p=26344219|t=2015. Growth and Quantification of MERS-CoV Infection.|pdf=|usr=015}} | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | {{tp|p= | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | {{tp|p= | + | |
− | + | ||
− | + | ||
{{tp|p=28444873|t=2017. Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus.|pdf=|usr=015}} | {{tp|p=28444873|t=2017. Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus.|pdf=|usr=015}} | ||
{{tp|p=28653496|t=2017. Middle East respiratory syndrome coronavirus experimental transmission using a pig model.|pdf=|usr=015}} | {{tp|p=28653496|t=2017. Middle East respiratory syndrome coronavirus experimental transmission using a pig model.|pdf=|usr=015}} | ||
+ | {{tp|p=28960494|t=2018. A study of the probable transmission routes of MERS-CoV during the first hospital outbreak in the Republic of Korea.|pdf=|usr=015}} | ||
+ | {{tp|p=29143192|t=2017. Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.|pdf=|usr=015}} | ||
{{tp|p=30520548|t=2019. Co?localization of Middle East respiratory syndrome coronavirus (MERS?CoV) and dipeptidyl peptidase?4 in the respiratory tract and lymphoid tissues of pigs and llamas |pdf=|usr=}} | {{tp|p=30520548|t=2019. Co?localization of Middle East respiratory syndrome coronavirus (MERS?CoV) and dipeptidyl peptidase?4 in the respiratory tract and lymphoid tissues of pigs and llamas |pdf=|usr=}} | ||
{{tp|p=31056437|t=2020. MERS-CoV infection among healthcare workers and risk factors for death: Retrospective analysis of all laboratory-confirmed cases reported to WHO from 2012 to 2 June 2018.|pdf=|usr=018}} | {{tp|p=31056437|t=2020. MERS-CoV infection among healthcare workers and risk factors for death: Retrospective analysis of all laboratory-confirmed cases reported to WHO from 2012 to 2 June 2018.|pdf=|usr=018}} | ||
{{tp|p=31256729|t=2020. Narrative review of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: updates and implications for practice.|pdf=|usr=018}} | {{tp|p=31256729|t=2020. Narrative review of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: updates and implications for practice.|pdf=|usr=018}} | ||
+ | {{tp|p=31279728|t=2020. Confronting the persisting threat of the Middle East respiratory syndrome to global health security.|pdf=|usr=018}} | ||
{{tp|p=31534035|t=2019. Diversity of Dromedary Camel Coronavirus HKU23 in African Camels Revealed Multiple Recombination Events among Closely Related Betacoronaviruses of the Subgenus Embecovirus.|pdf=|usr=018}} | {{tp|p=31534035|t=2019. Diversity of Dromedary Camel Coronavirus HKU23 in African Camels Revealed Multiple Recombination Events among Closely Related Betacoronaviruses of the Subgenus Embecovirus.|pdf=|usr=018}} | ||
− | |||
{{tp|p=31562757|t=2020. Activation of C-Type Lectin Receptor and (RIG)-I-Like Receptors Contributes to Proinflammatory Response in Middle East Respiratory Syndrome Coronavirus-Infected Macrophages.|pdf=|usr=018}} | {{tp|p=31562757|t=2020. Activation of C-Type Lectin Receptor and (RIG)-I-Like Receptors Contributes to Proinflammatory Response in Middle East Respiratory Syndrome Coronavirus-Infected Macrophages.|pdf=|usr=018}} | ||
{{tp|p=31592752|t=2019. Isolation and growth characterization of novel full length and deletion mutant human MERS-CoV strains from clinical specimens collected during 2015.|pdf=|usr=018}} | {{tp|p=31592752|t=2019. Isolation and growth characterization of novel full length and deletion mutant human MERS-CoV strains from clinical specimens collected during 2015.|pdf=|usr=018}} | ||
− | {{tp|p= | + | {{tp|p=31668197|t=2019. The Middle East Respiratory Syndrome (MERS).|pdf=|usr=018}} |
+ | {{tp|p=31706200|t=2020. MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract.|pdf=|usr=018}} | ||
+ | {{tp|p=31727466|t=2020. Focus on Middle East respiratory syndrome coronavirus (MERS-CoV).|pdf=|usr=018}} | ||
+ | {{tp|p=31730910|t=2019. MERS-CoV as an emerging respiratory illness: A review of prevention methods.|pdf=|usr=018}} | ||
+ | {{tp|p=31776269|t=2020. Molecular Basis of Binding between Middle East Respiratory Syndrome Coronavirus and CD26 from Seven Bat Species.|pdf=|usr=018}} | ||
+ | {{tp|p=31792450|t=2019. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors.|pdf=|usr=018}} | ||
{{tp|p=31838832|t=2020. Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis.|pdf=|usr=018}} | {{tp|p=31838832|t=2020. Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis.|pdf=|usr=018}} | ||
{{tp|p=31852899|t=2019. SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection.|pdf=|usr=018}} | {{tp|p=31852899|t=2019. SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection.|pdf=|usr=018}} | ||
{{tp|p=31855530|t=2020. Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi Arabia.|pdf=|usr=018}} | {{tp|p=31855530|t=2020. Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi Arabia.|pdf=|usr=018}} | ||
− | |||
{{tp|p=31883083|t=2020. Studying Evolutionary Adaptation of MERS-CoV.|pdf=|usr=018}} | {{tp|p=31883083|t=2020. Studying Evolutionary Adaptation of MERS-CoV.|pdf=|usr=018}} | ||
{{tp|p=31883084|t=2020. Evaluating MERS-CoV Entry Pathways.|pdf=|usr=018}} | {{tp|p=31883084|t=2020. Evaluating MERS-CoV Entry Pathways.|pdf=|usr=018}} | ||
Zeile 49: | Zeile 34: | ||
{{tp|p=31883089|t=2020. Antigen Capture Enzyme-Linked Immunosorbent Assay for Detecting Middle East Respiratory Syndrome Coronavirus in Humans.|pdf=|usr=018}} | {{tp|p=31883089|t=2020. Antigen Capture Enzyme-Linked Immunosorbent Assay for Detecting Middle East Respiratory Syndrome Coronavirus in Humans.|pdf=|usr=018}} | ||
{{tp|p=31883090|t=2020. Quantification of the Middle East Respiratory Syndrome-Coronavirus RNA in Tissues by Quantitative Real-Time RT-PCR.|pdf=|usr=018}} | {{tp|p=31883090|t=2020. Quantification of the Middle East Respiratory Syndrome-Coronavirus RNA in Tissues by Quantitative Real-Time RT-PCR.|pdf=|usr=018}} | ||
− | {{tp|p= | + | {{tp|p=31883091|t=2020. Evaluation of MERS-CoV Neutralizing Antibodies in Sera Using Live Virus Microneutralization Assay.|pdf=|usr=018}} |
− | {{tp|p= | + | {{tp|p=31883092|t=2020. Generation of MERS-CoV Pseudotyped Viral Particles for the Evaluation of Neutralizing Antibodies in Mammalian Sera.|pdf=|usr=018}} |
− | {{tp|p= | + | {{tp|p=31883093|t=2020. Qualitative and Quantitative Determination of MERS-CoV S1-Specific Antibodies Using ELISA.|pdf=|usr=018}} |
− | {{tp|p= | + | {{tp|p=31883094|t=2020. Genetically Engineering a Susceptible Mouse Model for MERS-CoV-Induced Acute Respiratory Distress Syndrome.|pdf=|usr=018}} |
− | {{tp|p= | + | {{tp|p=31883095|t=2020. Development of a Mouse-Adapted MERS Coronavirus.|pdf=|usr=018}} |
− | {{tp|p= | + | {{tp|p=31924756|t=2020. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.|pdf=|usr=018}} |
− | {{tp|p= | + | {{tp|p=31945421|t=2020. Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein.|pdf=|usr=018}} |
− | {{tp|p= | + | {{tp|p=31959375|t=2020. The risk factors associated with MERS-CoV patient fatality: A global survey.|pdf=|usr=018}} |
− | {{tp|p= | + | {{tp|p=31961300|t=2020. Middle East Respiratory Syndrome Coronavirus Transmission.|pdf=|usr=018}} |
− | {{tp|p= | + | {{tp|p=31964246|t=2020. Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus.|pdf=|usr=018}} |
− | {{tp|p= | + | {{tp|p=32004690|t=2020. Middle East respiratory syndrome coronavirus (MERS-CoV) - Surveillance and testing in North England from 2012 to 2019.|pdf=|usr=018}} |
− | {{tp|p= | + | {{tp|p=32011472|t=2020. Effect of isolation practice on the transmission of middle east respiratory syndrome coronavirus among hemodialysis patients: A 2-year prospective cohort study.|pdf=|usr=018}} |
− | {{tp|p= | + | {{tp|p=32042254|t=2020. Identifying factors and target preventive therapies for Middle East Respiratory Syndrome sucsibtable patients.|pdf=|usr=018}} |
− | {{tp|p= | + | {{tp|p=32059047|t=2020. A realistic two-strain model for MERS-CoV infection uncovers the high risk for epidemic propagation.|pdf=|usr=018}} |
+ | {{tp|p=32145185|t=2020. Middle East respiratory syndrome |pdf=|usr=}} | ||
+ | {{tp|p=32150528|t=2020. Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies.|pdf=|usr=018}} | ||
+ | {{tp|p=32152361|t=2020. Topological dynamics of the 2015 South Korea MERS-CoV spread-on-contact networks.|pdf=|usr=018}} | ||
+ | {{tp|p=32213260|t=2020. Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.|pdf=|usr=015}} | ||
+ | {{tp|p=32223537|t=2020. Competing endogenous RNA network profiling reveals novel host dependency factors required for MERS-CoV propagation.|pdf=|usr=018}} | ||
+ | {{tp|p=32239666|t=2020. Porcine deltacoronavirus infection alters bacterial communities in the colon and feces of neonatal piglets.|pdf=|usr=018}} | ||
+ | {{tp|p=32307315|t=2020. The first clusters of Middle East respiratory syndrome coronavirus in Oman: Time to act.|pdf=|usr=018}} | ||
+ | {{tp|p=32354534|t=2020. Demographic, clinical, and outcomes of confirmed cases of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in Najran, Kingdom of Saudi Arabia (KSA); A retrospective record based study.|pdf=|usr=018}} | ||
+ | {{tp|p=32370153|t=2020. Molecular Evolution and Structural Mapping of N-Terminal Domain in Spike Gene of Middle East Respiratory Syndrome Coronavirus (MERS-CoV).|pdf=|usr=018}} | ||
+ | {{tp|p=32503352|t=2020. Genomic Sequencing and Analysis of Eight Camel-Derived Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Isolates in Saudi Arabia.|pdf=|usr=007}} | ||
{{tp|p=32543343|t=2020. Some pathological observations on the naturally infected dromedary camels (Camelus dromedarius) with the Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia 2018-2019.|pdf=|usr=018}} | {{tp|p=32543343|t=2020. Some pathological observations on the naturally infected dromedary camels (Camelus dromedarius) with the Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia 2018-2019.|pdf=|usr=018}} | ||
{{tp|p=32552831|t=2020. Challenge infection model for MERS-CoV based on naturally infected camels.|pdf=|usr=018}} | {{tp|p=32552831|t=2020. Challenge infection model for MERS-CoV based on naturally infected camels.|pdf=|usr=018}} | ||
− | {{tp|p= | + | {{tp|p=32645711|t=2020. Assessment of Th1/Th2 cytokines among patients with Middle East respiratory syndrome coronavirus infection.|pdf=|usr=018}} |
+ | {{tp|p=32654959|t=?. Evolving sequence mutations in the Middle East Respiratory Syndrome Coronavirus (MERS-CoV).|pdf=|usr=015}} | ||
+ | {{tp|p=32738607|t=2020. The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.|pdf=|usr=017}} | ||
+ | {{tp|p=32747502|t=2020. Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKepsilon.|pdf=|usr=018}} | ||
+ | {{tp|p=32773137|t=2020. Middle East Respiratory Syndrome (MERS) Coronavirus.|pdf=|usr=018}} | ||
+ | {{tp|p=32782912|t=2020. Prolonged (6-Month) Shedding of Middle East Respiratory Syndrome Coronavirus RNA in the Sputum of a Lymphoma Patient.|pdf=|usr=018}} | ||
+ | {{tp|p=32801842|t=2020. Middle East Respiratory Syndrome - What Every Otolaryngologist Should Know: A Review.|pdf=|usr=018}} | ||
+ | {{tp|p=32803835|t=2020. Comparative analysis of the genome structure and organization of the Middle East respiratory syndrome coronavirus (MERS-CoV) 2012 to 2019 revealing evidence for virus strain barcoding, zoonotic transmission, and selection pressure.|pdf=|usr=018}} | ||
+ | {{ttp|p=28858401|t=2018. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study.|pdf=|usr=015}} |
Aktuelle Version vom 30. September 2020, 10:53 Uhr
no systematic search by-topic.
24456414 2014. Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005.
26256102 2017. Dromedary Camels and the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
26344219 2015. Growth and Quantification of MERS-CoV Infection.
28444873 2017. Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus.
28653496 2017. Middle East respiratory syndrome coronavirus experimental transmission using a pig model.
28960494 2018. A study of the probable transmission routes of MERS-CoV during the first hospital outbreak in the Republic of Korea.
29143192 2017. Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.
30520548 2019. Co?localization of Middle East respiratory syndrome coronavirus (MERS?CoV) and dipeptidyl peptidase?4 in the respiratory tract and lymphoid tissues of pigs and llamas
31056437 2020. MERS-CoV infection among healthcare workers and risk factors for death: Retrospective analysis of all laboratory-confirmed cases reported to WHO from 2012 to 2 June 2018.
31256729 2020. Narrative review of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: updates and implications for practice.
31279728 2020. Confronting the persisting threat of the Middle East respiratory syndrome to global health security.
31534035 2019. Diversity of Dromedary Camel Coronavirus HKU23 in African Camels Revealed Multiple Recombination Events among Closely Related Betacoronaviruses of the Subgenus Embecovirus.
31562757 2020. Activation of C-Type Lectin Receptor and (RIG)-I-Like Receptors Contributes to Proinflammatory Response in Middle East Respiratory Syndrome Coronavirus-Infected Macrophages.
31592752 2019. Isolation and growth characterization of novel full length and deletion mutant human MERS-CoV strains from clinical specimens collected during 2015.
31668197 2019. The Middle East Respiratory Syndrome (MERS).
31706200 2020. MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract.
31727466 2020. Focus on Middle East respiratory syndrome coronavirus (MERS-CoV).
31730910 2019. MERS-CoV as an emerging respiratory illness: A review of prevention methods.
31776269 2020. Molecular Basis of Binding between Middle East Respiratory Syndrome Coronavirus and CD26 from Seven Bat Species.
31792450 2019. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors.
31838832 2020. Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis.
31852899 2019. SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection.
31855530 2020. Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi Arabia.
31883083 2020. Studying Evolutionary Adaptation of MERS-CoV.
31883084 2020. Evaluating MERS-CoV Entry Pathways.
31883085 2020. Biochemical Characterization of Middle East Respiratory Syndrome Coronavirus Spike Protein Proteolytic Processing.
31883086 2020. Crystallization and Structural Determination of the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein.
31883087 2020. Bacterial Artificial Chromosome-Based Lambda Red Recombination with the I-SceI Homing Endonuclease for Genetic Alteration of MERS-CoV.
31883088 2020. Deducing the Crystal Structure of MERS-CoV Helicase.
31883089 2020. Antigen Capture Enzyme-Linked Immunosorbent Assay for Detecting Middle East Respiratory Syndrome Coronavirus in Humans.
31883090 2020. Quantification of the Middle East Respiratory Syndrome-Coronavirus RNA in Tissues by Quantitative Real-Time RT-PCR.
31883091 2020. Evaluation of MERS-CoV Neutralizing Antibodies in Sera Using Live Virus Microneutralization Assay.
31883092 2020. Generation of MERS-CoV Pseudotyped Viral Particles for the Evaluation of Neutralizing Antibodies in Mammalian Sera.
31883093 2020. Qualitative and Quantitative Determination of MERS-CoV S1-Specific Antibodies Using ELISA.
31883094 2020. Genetically Engineering a Susceptible Mouse Model for MERS-CoV-Induced Acute Respiratory Distress Syndrome.
31883095 2020. Development of a Mouse-Adapted MERS Coronavirus.
31924756 2020. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
31945421 2020. Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein.
31959375 2020. The risk factors associated with MERS-CoV patient fatality: A global survey.
31961300 2020. Middle East Respiratory Syndrome Coronavirus Transmission.
31964246 2020. Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus.
32004690 2020. Middle East respiratory syndrome coronavirus (MERS-CoV) - Surveillance and testing in North England from 2012 to 2019.
32011472 2020. Effect of isolation practice on the transmission of middle east respiratory syndrome coronavirus among hemodialysis patients: A 2-year prospective cohort study.
32042254 2020. Identifying factors and target preventive therapies for Middle East Respiratory Syndrome sucsibtable patients.
32059047 2020. A realistic two-strain model for MERS-CoV infection uncovers the high risk for epidemic propagation.
32145185 2020. Middle East respiratory syndrome
32150528 2020. Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies.
32152361 2020. Topological dynamics of the 2015 South Korea MERS-CoV spread-on-contact networks.
32213260 2020. Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.
32223537 2020. Competing endogenous RNA network profiling reveals novel host dependency factors required for MERS-CoV propagation.
32239666 2020. Porcine deltacoronavirus infection alters bacterial communities in the colon and feces of neonatal piglets.
32307315 2020. The first clusters of Middle East respiratory syndrome coronavirus in Oman: Time to act.
32354534 2020. Demographic, clinical, and outcomes of confirmed cases of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in Najran, Kingdom of Saudi Arabia (KSA); A retrospective record based study.
32370153 2020. Molecular Evolution and Structural Mapping of N-Terminal Domain in Spike Gene of Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
32503352 2020. Genomic Sequencing and Analysis of Eight Camel-Derived Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Isolates in Saudi Arabia.
32543343 2020. Some pathological observations on the naturally infected dromedary camels (Camelus dromedarius) with the Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia 2018-2019.
32552831 2020. Challenge infection model for MERS-CoV based on naturally infected camels.
32645711 2020. Assessment of Th1/Th2 cytokines among patients with Middle East respiratory syndrome coronavirus infection.
32654959 ?. Evolving sequence mutations in the Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
32738607 2020. The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.
32747502 2020. Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKepsilon.
32773137 2020. Middle East Respiratory Syndrome (MERS) Coronavirus.
32782912 2020. Prolonged (6-Month) Shedding of Middle East Respiratory Syndrome Coronavirus RNA in the Sputum of a Lymphoma Patient.
32801842 2020. Middle East Respiratory Syndrome - What Every Otolaryngologist Should Know: A Review.
32803835 2020. Comparative analysis of the genome structure and organization of the Middle East respiratory syndrome coronavirus (MERS-CoV) 2012 to 2019 revealing evidence for virus strain barcoding, zoonotic transmission, and selection pressure.
28858401 2018. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study. |